High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, crossover study

Neurology

Volumn 40, Issue 2, 1990, Pages 209-212

  Van Doorn, Pieter A ^a   Brand, A ^b   Strengers, P F W ^c   Meulstee, J ^a   Vermeulen, M ^a  

^a Department of Neurology ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMYELINATING NEUROPATHY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CONDUCTION; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; CHILD; CHRONIC DISEASE; DEMYELINATING DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMAN; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGE; NEURAL CONDUCTION; POLYNEUROPATHIES; POLYRADICULONEUROPATHY; RANDOMIZED CONTROLLED TRIALS;

EID: 0025343185     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.40.2.209     Document Type: Article

References (15)

1. Dyck PJ, Lais AC, Ohta M, et al. Chronic inflammatory poly-radiculoneuropathy. Mayo Clin Proc 1975;50:621–637.
2. Dyck PJ, O’Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136–141.
3. Dyck PJ, Daube J, O’Brien PC, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986;314:461–465.
4. Vermeulen M, van der Meché FGA, Speelman JD, Weber A, Busch HFM. Plasma and gammaglobulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci 1985;70:317–326.
5. Albama M, McNamara ME, Sokol M, Wijshock E. Improvement of neurologic function in chronic inflammatory demyelinating polyradiculoneuropathy following intravenous gammaglobulin infusion. Arch Neurol 1987;44:248–249.
6. Cook JD, Delgrado MR, Soutter-Glass D. Treatment of childhood autoimmune polyneuropathy: IV gammaglobulin [Abstract]. Neurology 1987;37(suppl 1):253.
7. Curró Dossi B, Tezzon F. High dose, intravenous gammaglobulin for chronic inflammatory demyelinating polyneuropathy. Ital J Neurol Sci 1987;8:321–326.
8. Faed JM, Day B, Pollock M, Taylor PK, Nukada H, Hammond-Tooke. High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Neurology 1989;39:422–425.
9. Dyck PJ, Arnason BGW. Chronic inflammatory demyelinating polyradiculoneuropathy, chap 91. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, vol 2, 2nd ed. Philadelphia: W.B. Saunders, 1984:2101–2114.
10. Skvaril F. Qualitative and quantitative aspects of IgG subclasses in i.v. immunoglobulin preparations. In: Nydegger UE, ed. Immu-nochemotherapy: a guide to immunoglobulin prophylaxis and therapy. London: Academic Press, 1981:113–122.
11. Van Swieten JC, Koudstaal PK, Visser MC, Schouten HJA, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
12. Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 1986;35:231–233.
13. Berkman SA. AIDS and plasma-derived products in the USA. In: Morell A, Nydegger UE, eds. Clinical use of intravenous immuno-globulins. London: Academic Press, 1986:399–409.
14. Lee ML, Courter SG, Tait D, Kingdon HS. Long-term evaluation of intravenous immune globulin preparation with regard to non-A, non-B hepatitis safety. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York Alan R. Liss, 1988:596–599.
15. Oosterhuis HJGH. Myasthenia gravis. Clinical neurology and neurosurgery monographs, vol 5. New York: Churchill Livingstone, 1984:175–208.